Our Third Conference

We are bringing together leading aging researchers and biotech investors for an action-packed event.


We will be returning in 2020 to host our third conference in New York City and brings together the leading experts in aging research and biotech business and investment. Building on the success of our 2018 and 2019 conferences we will continue to bring you the latest research, business, and investment talks from some of the top leaders in their fields.

We will be releasing more information about the conference in the coming months as we confirm speakers, venue, and dates. If you would like to stay informed about developments and ticket offers you may wish to sign up for the conference mailing list below.


Dr. Judith Campisi

The Buck Institute

Dr. Aubrey de Grey

SENS Research Foundation

Dr. Hanadie Yousef

Juvena Therapeutics

Dr. Steve Horvath

David Geffen School of Medicine, UCLA

Dr. Brian Kennedy

National University Singapore

Polina Mamoshina

Insilico Medicine

Dr. Alexey Moskalev

Russian Academy of Sciences

Dr. Andrei Gudkov

Roswell Park Comprehensive Cancer Center

Dr. Matthew O’Connor

Underdog Pharmaceuticals

Dr. Oliver Medvedik

Kanbar Center for Biomedical Engineering



We will be announcing our range of sponsorship deals for the conference shortly so keep an eye on this page to find out how you and your company can take part.


LEAF has become one of the world’s most important forces in spearheading the crusade to bring aging to an end. Their advocacy work continues to gain prominence, and with their series of New York conferences, they are now bringing the most cutting-edge scientific advances to a general audience. These fantastic events are an invaluable US counterpart to the ones that SENS Research Foundation runs in Berlin, and they are making a great contribution to the anti-aging crusade.

– Dr. Aubrey de Grey, SENS Research Foundation

I can’t think of a better way for a venue to accelerate breakthroughs in human longevity than to put leading scientists and investors in the same room. The scientists get to directly meet investors and learn about the present and future funding landscape, while the investors get to meet key scientists and keep on top of the state of the art in the field of longevity research.

– Dr. Oliver Medvedik, Kanbar Center for Biomedical Engineering

Because of the nature of my work I get to go to several international conferences every year. I attended the Ending Age-Related Disease conference in NY this year and it is now at the top of my list. A perfect sized event with exceptional speakers and flawlessly ran, ideal for learning the latest in the Longevity field, both on the scientific and investment side of things. Also, great for networking and connecting with fellow longevitists. Well done Lifespan team!

– Maria Entraigues, SENS Research Foundation

I’m grateful that there are a growing number of people that are interested in studying and conquering aging and age-related diseases!

– Professor Michael Lustgarten, Tufts University


The Life Extension Advocacy Foundation volunteers once again put on a great conference in Manhattan, attracting some of the most influential researchers, investors, and entrepreneurs involved in the new and growing field of human rejuvenation. The event was characterized by extremely interesting presentations, ideas, and new data from work in progress in labs and companies. These are exciting times, and Ending Age-Related Diseases is a conference series well worth adding to your conference schedule.

– Reason, Repair Biotechnologies